Follow up by General Practitioner After Self-poisoning

Suicidal and Self-injurious Behaviour Clinical Trial

Official title:

Follow up After Self-poisoning by General Practitioner- a Randomised Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01342809
• Other study ID #: S-08708b
• Status: Completed
• Phase: N/A
• First received: April 18, 2011
• Last updated: May 6, 2014
• Start date: November 2009
• Est. completion date: May 2014

Study information

• Verified date: May 2014
• Source: Oslo University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Norway: Oslo University Hospital Personvernombudet
• Study type: Interventional

Clinical Trial Summary

The study hypothesis is that follow up from general practitioner after hospitalization for self poisoning will decrease suicidal behaviour.

Description:

Patients hospitalized after an episode of self poisoning will be randomly assigned into intervention an control groups. The intervention is close follow up by general practitioner six months. Both groups will receive treatment as usual.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 202
• Est. completion date: May 2014
• Est. primary completion date: November 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Self Poisoning (according to the WHO definition)

• Ability to fill out questionnaire

Exclusion Criteria:

• Hospitalization into psychiatric ward

• Unknown address or ID

• Not registered with General Practitioner

• If institutionalized or in jail.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Self-Injurious Behavior
• Suicidal and Self-injurious Behaviour

Intervention

Behavioral:
• Follow up
Follow up, consultations with general practitioner, written guidelines, supervision.

Locations

Country	Name	City	State
Norway	Oslo University Hospital	Oslo

Sponsors (4)

Lead Sponsor	Collaborator
Oslo University Hospital	Diakonhjemmet Hospital, Lovisenberg Diakonale Hospital, University Hospital, Akershus

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Suicidal behaviour	Beck Cepression Inventory, Beck Hopelessness scale, Beck Suicide Ideation Scale	3 and 6 months	No
Primary	Suicidal behaviour	Beck Depression Inventory, Beck Hopelessness scale, Beck Suicide Ideation Scale	3 and 6 months	No
Secondary	Treatment	Contacts with GP, and health care services, satisfaction with treatment GP (EUROPEP)	3 and 6 months	No